CD155 immunohistochemical expression in upper tract urothelial carcinoma predicts poor prognosis
Junichi Ikeda(Kansai Medical University), Hidefumi Kinoshita(Kansai Medical University)
Cited by 4
Related Papers
Hypoxia inducible factor‐1 activator munc‐18‐interacting protein 3 promotes tumour progression in urothelial carcinoma
|Clinical and Translational Discovery|2023|4